Haemonetics Corp expected to post earnings of 80cents a share - Earnings Preview

Haemonetics

03/02/2023 11:44

* Haemonetics Corp  HAE.N   HAE  is expected to show a rise
in
quarterly revenue when it reports  results on February 7. 
    * The Boston Massachusetts-based  company is expected to
report  a
15.7% increase in revenue to $300.47 million from $259.77
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Haemonetics Corp is
for
earnings of 80 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Haemonetics
Corp
is $94​, above​ its last closing price of $86.37. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  0.68        0.67       0.83      Beat    23.2
 Jun. 30 2022  0.51        0.51       0.58      Beat    13.6
 Mar. 31 2022  0.60        0.60       0.65      Beat    8.2​
 Dec. 31 2021  0.73        0.73       0.84      Beat    14.4
 ​​Sep.        0.61        0.61       0.60      Missed  -1
 30 2021                                                
 Jun. 30 2021  0.45        0.45       0.50      Beat    11.1​
 Mar. 31 2021  0.67        0.67       0.46      Missed  -31.5
 Dec. 31 2020  0.66        0.65       0.81      Beat    23.8
 This summary was machine generated February 3 at 11:44 GMT.  All
figures in US dollars  unless otherwise stated